Asia-Pacific Health 2020 and Genomics without Borders: Co-production of Knowledge by Science and Society Partnership for Global Personalized Medicine

Current Pharmacogenomics and Personalized Medicine

Volumn 9, Issue 1, 2011, Pages 1-5

  Ozdemir, Vural ^a   Muljono, David H ^b   Pang, Tikki ^c   Ferguson, Lynnette R ^d,e   Manamperi, Aresha ^f   Samper, Sofia ^g   Someya, Toshiyuki ^h   Tassé, Anne Marie ^a   Tsai, Shih Jen ⁱ   Zhou, Hong Hao ^j   Lee, Edmund J D ^k  

^a MCGILL UNIVERSITY   (Canada)

^b EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d THE UNIVERSITY OF AUCKLAND   (New Zealand)

^e Nutrigenomics New Zealand   (New Zealand)

^f UNIVERSITY OF KELANIYA   (Sri Lanka)

^g UNIVERSITY OF SUSSEX   (United Kingdom)

^h NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

ⁱ TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^j CENTRAL SOUTH UNIVERSITY   (China)

^k NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

more..

Author keywords

Asia pacific; Genomics and international development; Global health; Health 2020 policy; Knowledge co production; Lmics; Public health genomics; Science and society

Indexed keywords

ASIA; EDITORIAL; GENETIC DATABASE; GENOMICS; HEALTH CARE POLICY; HEALTH STATUS; HIGH THROUGHPUT SCREENING; MEDICAL RESEARCH; MEDICAL SOCIETY; METABOLOMICS; PACIFIC ISLANDS; PERSONALIZED MEDICINE; PROFESSIONAL PRACTICE; PROTEOMICS; SCIENCE;

EID: 79952743907     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569211794728841     Document Type: Editorial

References (55)

1. Jasanoff S. Technologies of humility. Nature 2007; 450(7166): 33.
2. Institute of International Education (IIE), press release, Washington, DC, November 15, 2010. Available from: http://www.iie.org/en/Research-and-Publications/Open-Doors [Accessed February 5, 2011].
3. Hather GJ, Haynes W, Higdon R, et al. The United States of America and scientific research. PLoS One 2010; 5(8): e12203.
4. Barnett MP, Ferguson LR. Meeting report: fourth Asia-Pacific nutrigenomics conference: gene-diet interactions in gut health, Auckland, New Zealand, February 21-25, 2010. Biotechnol J 2010; 5(9): 913-8.
5. Ranganathan S, Eisenhaber F, Tong JC, et al. Extending Asia Pacific bioinformatics into new realms in the -omics era. BMC Genomics 2009; 10 (Suppl 3): S1.
6. Manamperi A, Nugawela P, Gunawardene NS, et al. RNA positivity rates among anti-HCV reactive blood donors in Sri Lanka: a preliminary study. Indian J Med Microbiol 2010; 28(3): 264-5.
7. Manamperi A. Current developments in genomics and personalized health care: impact on public health. Asia Pac J Public Health 2008; 20(3): 242-50.
8. Normile D. The promise and pitfalls of clinical trials overseas. Science 2008; 322: 214-6.
9. Ozdemir V, Husereau D, Hyland S, et al. Personalized medicine beyond genomics: New technologies, global health diplomacy and anticipatory governance. Curr Pharmacogenomics Person Med 2009; 7(4): 225-30.
10. Ozdemir V, Someya T. A transdisciplinary forum for study of individual and population variability in response to health interventions and personalized medicine. Curr Pharmacogenomics Person Med 2009; 7(3): 146-8.
11. European Commission, Europe 2020, EU-Wide Targets. Available from: http://ec.europa.eu/europe2020/targets/eu-targets/index_en.htm [Accessed February 5, 2011].
12. Pang T. Germs, genomics and global public health: How can advances in genomic sciences be integrated into public health in the developing world to deal with infectious diseases? Hugo J 2009; 3(1-4): 5-9.
13. Serour GI. Healthcare workers and the brain drain. Int J Gynaecol Obstet 2009; 106(2): 175-8.
14. Dodani S, LaPorte RE. Ways to strengthen research capacity in developing countries: effectiveness of a research training workshop in Pakistan. Public Health 2008; 122(6): 578-87.
15. Roelofsen A, Boon WPC, Kloet RR, et al. Stakeholder interaction within research consortia on emerging technologies: Learning how and what? Res Policy 2011; doi:10.1016/j.respol.2010.10.015.
16. Owen R, Goldberg N. Responsible innovation: a pilot study with the U.K. Engineering and physical sciences research council. Risk Anal 2010; 30(11): 1699-707.
17. Jakab Z. Message from the WHO Regional Director for Europe: Embarking on Developing the New European Health Policy-- Health 2020. Eur J Public Health 2011; 21(1): 131.
18. Ogburn WF. Social Change. New York: Dell 1922.
19. Godin B. The linear model of innovation. The historical construction of an analytical framework. Sci Technol Hum Values 2006; 31(6): 639-67.
20. Guston DH. Innovation policy: not just a jumbo shrimp. Nature 2008; 454(7207): 940-1.
21. Polanyi M. The Republic of Science: Its political and economic theory. Minerva 1962; 1(1): 54-74.
22. Fuglsang L. Three perspectives in STS in the policy context. In: Cutcliffe SH, Mitcham C, Eds. Visions of STS: Counterpoints in Science, Technology, and Society Studies. New York: State University of New York Press 2001; pp. 33-49.
23. Jorgensen MS, Jorgensen U, Clausen C. The social shaping approach to technology foresight. Futures 2009; 41(2): 80-6.
24. McGrail S. Nano dreams and nightmares: emerging technoscience and the framing and (re)interpreting of the future, present and past. J Fut Stud 2010; 14(4): 23-48.
25. Tallacchini M. Before and beyond the precautionary principle: epistemology of uncertainty in science and law. Toxicol Appl Pharmacol 2005; 207(Suppl 2): 645-51.
26. Ozdemir V, Armengaud J, Dubé L, et al. Nutriproteomics and proteogenomics: Cultivating two novel hybrid fields of personalized medicine with added societal value. Curr Pharmacogenomics Person Med 2010; 8(4): 240-3.
27. Miles I. The development of technology foresight: A review. Technol Forecast Soc Change 2010; 77(9): 1448-56.
28. Hewlett S, De Wit M, Richards P, et al. Patients and professionals as research partners: challenges, practicalities and benefits. Arthritis Rheum 2006; 55: 676-80.
29. Kato K, Kano K, Shirai T. Science communication: significance for genome-based personalized medicine - a view from the Asia-Pacific. Curr Pharmacogenomics Person Med 2010; 8(2): 92-6.
30. Innvaer S, Vist G, Trommald M, et al. Health policy makers' perceptions of their use of evidence: a systematic review. J Health Serv Res Policy 2002; 7: 239-44.
31. Choi BC, Pang T, Lin V, et al. Can scientists and policy makers work together? J Epidemiol Commun Health 2005; 59(8): 632-7.
32. Lavis J, Ross S, Hurley J, et al. Reflections on the role of healthservices research in public policy-making. paper 01-06. Available from: http://www.cihr-irsc.gc.ca/e/26574.html [Accessed February 5, 2011].
33. van Kerkhoff L, Szlezák N. Linking local knowledge with global action: examining the Global Fund to Fight AIDS, Tuberculosis and Malaria through a knowledge system lens. Bull World Health Organ 2006; 84(8): 629-35.
34. Tan CY. Science star over Asia. PLoS Biol 2005; 3(9): e322.
35. Fortier I, Burton PR, Robson PJ, et al. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol 2010; 39(5): 1383-93.
36. Fortin S, Pathmasiri S, Grintuch R, et al. 'Access arrangements' for biobanks: A fine line between facilitating and hindering collaboration. Public Health Genomics 2010. [Epub ahead of print].
37. Tassé AM, Budin-Ljøsne I, Knoppers BM, et al. Retrospective access to data: the ENGAGE consent experience. Eur J Hum Genet 2010; 18(7): 741-5.
38. Pang T, Daulaire N, Keusch G, et al. The new age of global health governance holds promise. Nat Med 2010; 16 (11): 1181.
39. Genes without Borders? Towards Global Genomics Governance. Available from: http://www.univie.ac.at/LSG/GwB/intro.htm [Accessed February 5, 2011].
40. Thorsteinsdóttir H, Ray M, Kapoor A, et al. Health biotechnology innovation on a global stage. Nat Rev Microbiol 2011; 9(2): 137-43.
41. European Network for Genetic and Genomic Epidemiology (ENGAGE). Available from: http://www.euengage.org/ [Accessed February 5, 2011].
42. Biobank Standardisation and Harmonisation for Research Excellence in the European Union (BioSHaRE). Available from: http://www.p3g.org/bioshare/?q=node [Accessed February 5, 2011].
43. Khoury MJ, Gwinn M, Yoon PW, et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007; 9(10): 665-74.
44. Khoury MJ., Muin J. Khoury discusses the future of public health genomics and why it matters for personalized medicine and global health. Curr Pharmacogenomics Person Med 2009; 7(3): 158-63. Available from: http://www.benthamscience.com/cppm/openaccessarticles/cppm7-3/003AF.pdf [Accessed February 5, 2011].
45. Ferguson LR, Hu R, Lam WJ, et al. Tailoring foods to match people's genes in New Zealand: opportunities for collaboration. World Rev Nutr Diet 2010; 101: 169-75.
46. Wittwer J, Rubio-Aliaga I, Hoeft B, et al. Nutrigenomics in human intervention studies: Current status, lessons learned and future perspectives. Mol Nutr Food Res 2011. [Epub ahead of print].
47. Kolker E. A vision for 21st century U.S. Policy to support sustainable advancement of scientific discovery and technological innovation. OMICS 2010; 14(4): 333-5.
48. Yearley S. The ethical landscape: identifying the right way to think about the ethical and societal aspects of synthetic biology research and products. J R Soc Interface 2009; 6 (Suppl 4): S559-64.
49. Gemici G. The metrics of the physician brain drain. N Engl J Med 2006; 354(5): 528-30.
50. Pang T. Pharmacogenomics and Personalized medicine for the developing world - Too soon or just-in-time? A Personal view from the World Health Organization. Curr Pharmacogenomics Person Med 2009; 7: 149-57.
51. Thedja MD, Muljono DH, Nurainy N, et al. Ethnogeographical structure of hepatitis B virus genotype B distribution in Indonesia and discovery of a new subgenotype, B9. Arch Virol 2011; DOI 10.1007/s00705-011-0926-y.
52. Coloma J, Harris E. Molecular genomic approaches to infectious diseases in resource-limited settings. PLoS Med 2009; 6(10): e1000142.
53. HUGO Pan-Asian SNP Consortium, Abdulla MA, Ahmed I, et al. Mapping human genetic diversity in Asia. Science 2009; 326(5959): 1541-5.
54. Law J. After method. Mess in social science research. New York: Routledge 2004.
55. Schofield PN, Eppig J, Huala E, et al. Sustaining the data and bioresource commons. Science 2010; 330(6004): 592-3.